Cytokines themselves traditionally have played a key role in cancer immunotherapy, with some being used as monotherapies (e.g., IL-2, IL-15) or in combinations with monoclonal antibodies (e.g., rituximab) or chemotherapeutics [101]. The gene discussed is IL15; the disease is cancer.